Market Overview:
The global prefilled syringe market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for prefilled syringes from the pharmaceutical and biotechnology industries, rising prevalence of chronic diseases, and technological advancements in prefilled syringe manufacturing processes. Based on type, the global prefilled syringe market is segmented into glass pre-filled syringes and polymer pre-filled syringes. Glass pre-filled syringes are more popular than polymer pre-filledsyringes due to their superior mechanical properties and chemical resistance as compared to polymers. However, polymerpre-filledsyringesis witnessing a higher growth rate due its advantages such as lightweightnessand biocompatibility over glasspre- filledsyringes. Based on application,the globalprefills yringe market is segmented intoautomated thrombotics devices (ATDs), vaccines, autoimmune diseases (ADs), others(including ophthalmic drugsand fertility drugs). The ATD segment accounts for themajorityof theglobalprefills yringemarket share owingtoits growing demandfrom hospitalsand clinicsfor accurate drug deliveryin critical care settings .
Product Definition:
A prefilled syringe is a medical device that consists of a syringe barrel with a plunger, and an attached needle. The barrel is filled with medication, and the needle is used to inject the medication into the body.
Glass Prefilled Syringes:
Glass pre-filled syringes are used for dispensing liquid into plastic and metal vials, ampoules or glass bottles. It is a type of injection molding machine that uses liquid material to create the shape of the desired object inside the container. The molten mixture is then transferred to another container through a tube and cooled. The process can be repeated multiple times until the desired number of objects are formed from raw materials such as plastic resin, rubber, etc.
Polymer Prefilled Syringes:
Polymer pre-filled syringes are used in the Prefilled Syringe market to deliver a precise dosage of liquid medicines. They are made up of plastic or other materials and can be customized as per requirement. The major advantage associated with these products is that they eliminate the need for users to measure out medicine doses themselves, thereby saving time and avoiding any errors that may occur due to manual dosing errors.
Application Insights:
The global prefilled syringe market is segmented based on application into vaccines, autoimmune diseases, other diseases and autithrombotics. The other disease segment held the largest share in 2017 due to increasing incidences of chronic conditions such as cancer and diabetes across the globe. Vaccines are expected to be one of the fastest-growing segments over the forecast period owing to growing demand for immunization against a wide range of vaccine-preventable diseases.
Prefilled syringes are used in vaccination procedures for injections that contain antigenic material from viruses or bacteria. With an increase in incidence of infectious and chronic disorders, there has been a rise in demand for immunization programs against these disorders globally.
Regional Analysis:
North America dominated the global prefilled syringe market in 2017. The presence of major players coupled with high disposable income and healthcare expenditure is expected to drive the regional market over the forecast period. In addition, increasing government initiatives for immunization programs are anticipated to fuel product demand in this region. For instance, according to a CDC fact sheet published on June 18, 2018 titledâ€Vaccines-pertussis coverage around the world: update through April 27th 2018†there were an estimated 10% more children aged 6 months - 17 years than age 2 years who had received at least one dose of DTaP vaccine (tetanus-diphtheria-acellular pertussis).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising awareness about immunizations among people as well as increasing investment by governments for improving healthcare infrastructure and reimbursement policies across emerging countries such as China and India.
Growth Factors:
- Increasing prevalence of chronic diseases: The prevalence of chronic diseases is increasing globally, which is expected to drive the demand for prefilled syringes. For instance, according to the World Health Organization (WHO), in 2015, around 38% of the global population was affected by one or more chronic diseases. This number is projected to increase to 45% by 2030.
- Technological advancements: The prefilled syringe market is witnessing significant advancements in technology, with manufacturers introducing new products and technologies such as smart needles and auto-disable needles. These technological advancements are expected to boost the growth of the market during the forecast period.
- Rising demand for self-injection devices: The demand for self-injection devices is rising due to their ease of use and portability. This is driving manufacturers to focus on developing innovative prefilled syringes that can be used with these devices safely and effectively. For instance, in 2017, Becton Dickinson introduced a new product called BD AutoShield Duo Prefilled Syringe System that can be used with all types of self-injection devices including pen injectors and insulin pumps .
Scope Of The Report
Report Attributes
Report Details
Report Title
Prefilled Syringe Market Research Report
By Type
Glass Prefilled Syringes, Polymer Prefilled Syringes
By Application
Autithrombotics, Vaccines, Autoimmune Diseases, Others
By Companies
BD(US), Gerresheimer(DE), Nipro Corporation(JP), Schott forma vitrum(DE), Ompi(IT), Baxter BioPharma Solution(US), ROVI CM(ES), Terumo(JP), Vetter(DE), Unilife Corporation(US), Taisei Kako(JP), Roselabs Group(IN), ARTE CORPORATION(JP), Weigao Group Medical Polymer(CN), Zibo Minkang Pharmaceutical(CN), Shandong Pharmaceutical Glass(CN)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Prefilled Syringe Market Report Segments:
The global Prefilled Syringe market is segmented on the basis of:
Types
Glass Prefilled Syringes, Polymer Prefilled Syringes
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Autithrombotics, Vaccines, Autoimmune Diseases, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD(US)
- Gerresheimer(DE)
- Nipro Corporation(JP)
- Schott forma vitrum(DE)
- Ompi(IT)
- Baxter BioPharma Solution(US)
- ROVI CM(ES)
- Terumo(JP)
- Vetter(DE)
- Unilife Corporation(US)
- Taisei Kako(JP)
- Roselabs Group(IN)
- ARTE CORPORATION(JP)
- Weigao Group Medical Polymer(CN)
- Zibo Minkang Pharmaceutical(CN)
- Shandong Pharmaceutical Glass(CN)
Highlights of The Prefilled Syringe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glass Prefilled Syringes
- Polymer Prefilled Syringes
- By Application:
- Autithrombotics
- Vaccines
- Autoimmune Diseases
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prefilled Syringe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A prefilled syringe is a syringe that has been filled with the patient's medication before it is given to them. This can be helpful for patients who are unable to take medications orally or who have difficulty remembering to take their medications on a regular basis.
Some of the key players operating in the prefilled syringe market are BD(US), Gerresheimer(DE), Nipro Corporation(JP), Schott forma vitrum(DE), Ompi(IT), Baxter BioPharma Solution(US), ROVI CM(ES), Terumo(JP), Vetter(DE), Unilife Corporation(US), Taisei Kako(JP), Roselabs Group(IN), ARTE CORPORATION(JP), Weigao Group Medical Polymer(CN), Zibo Minkang Pharmaceutical(CN), Shandong Pharmaceutical Glass(CN).
The prefilled syringe market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Prefilled Syringe Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Prefilled Syringe Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Prefilled Syringe Market - Supply Chain
4.5. Global Prefilled Syringe Market Forecast
4.5.1. Prefilled Syringe Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Prefilled Syringe Market Size (000 Units) and Y-o-Y Growth
4.5.3. Prefilled Syringe Market Absolute $ Opportunity
5. Global Prefilled Syringe Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Prefilled Syringe Market Size and Volume Forecast by Type
5.3.1. Glass Prefilled Syringes
5.3.2. Polymer Prefilled Syringes
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Prefilled Syringe Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Prefilled Syringe Market Size and Volume Forecast by Application
6.3.1. Autithrombotics
6.3.2. Vaccines
6.3.3. Autoimmune Diseases
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Prefilled Syringe Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Prefilled Syringe Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Prefilled Syringe Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Prefilled Syringe Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Prefilled Syringe Demand Share Forecast, 2019-2029
9. North America Prefilled Syringe Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Prefilled Syringe Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Prefilled Syringe Market Size and Volume Forecast by Application
9.4.1. Autithrombotics
9.4.2. Vaccines
9.4.3. Autoimmune Diseases
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Prefilled Syringe Market Size and Volume Forecast by Type
9.7.1. Glass Prefilled Syringes
9.7.2. Polymer Prefilled Syringes
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Prefilled Syringe Demand Share Forecast, 2019-2029
10. Latin America Prefilled Syringe Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Prefilled Syringe Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Prefilled Syringe Market Size and Volume Forecast by Application
10.4.1. Autithrombotics
10.4.2. Vaccines
10.4.3. Autoimmune Diseases
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Prefilled Syringe Market Size and Volume Forecast by Type
10.7.1. Glass Prefilled Syringes
10.7.2. Polymer Prefilled Syringes
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Prefilled Syringe Demand Share Forecast, 2019-2029
11. Europe Prefilled Syringe Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Prefilled Syringe Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Prefilled Syringe Market Size and Volume Forecast by Application
11.4.1. Autithrombotics
11.4.2. Vaccines
11.4.3. Autoimmune Diseases
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Prefilled Syringe Market Size and Volume Forecast by Type
11.7.1. Glass Prefilled Syringes
11.7.2. Polymer Prefilled Syringes
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Prefilled Syringe Demand Share, 2019-2029
12. Asia Pacific Prefilled Syringe Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Prefilled Syringe Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Prefilled Syringe Market Size and Volume Forecast by Application
12.4.1. Autithrombotics
12.4.2. Vaccines
12.4.3. Autoimmune Diseases
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Prefilled Syringe Market Size and Volume Forecast by Type
12.7.1. Glass Prefilled Syringes
12.7.2. Polymer Prefilled Syringes
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Prefilled Syringe Demand Share, 2019-2029
13. Middle East & Africa Prefilled Syringe Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Prefilled Syringe Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Prefilled Syringe Market Size and Volume Forecast by Application
13.4.1. Autithrombotics
13.4.2. Vaccines
13.4.3. Autoimmune Diseases
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Prefilled Syringe Market Size and Volume Forecast by Type
13.7.1. Glass Prefilled Syringes
13.7.2. Polymer Prefilled Syringes
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Prefilled Syringe Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Prefilled Syringe Market: Market Share Analysis
14.2. Prefilled Syringe Distributors and Customers
14.3. Prefilled Syringe Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD(US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Gerresheimer(DE)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nipro Corporation(JP)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Schott forma vitrum(DE)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ompi(IT)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Baxter BioPharma Solution(US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ROVI CM(ES)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Terumo(JP)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Vetter(DE)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Unilife Corporation(US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Taisei Kako(JP)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Roselabs Group(IN)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. ARTE CORPORATION(JP)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Weigao Group Medical Polymer(CN)
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Zibo Minkang Pharmaceutical(CN)
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Shandong Pharmaceutical Glass(CN)
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
